Part 9 Drug (MOA)

Blocks angiotensin converting enzymes, preventing formation of angoitesion II. Improves cardiac output.

Blocks angiotensin converting enzymes, preventing formation of angoitesion II. Improves cardiac output.

Increases inotrophy (contractility) with litte effect on chronotropy (heart rate) or vasculatures. Indications: Congestive heart failure.

Inhibits the formation of new clots.

Increases blood pressure and cardiac output by increasing the "big 4" through beta-1 stimulation.

Combines with adenosine triphosphate